World Health Organization (2023) WHO report on the global tobacco epidemic, 2023: protect people from tobacco smoke. https://www.who.int/publications-detail-redirect/9789240077164. Accessed 25 Nov 2024

Holtjer JCS, Bloemsma LD, Beijers RJHCG, Cornelissen MEB, Hilvering B, Houweling L, Vermeulen RCH, Downward GS, Maitland-Van der Zee AH, P4O2 consortium (2023) Identifying risk factors for COPD and adult-onset asthma: an umbrella review. Eur Respir Rev 32:230009. https://doi.org/10.1183/16000617.0009-2023

Alarcon-Calderon A, Vassallo R, Yi ES, Ryu JH (2023) Smoking-related interstitial lung diseases. Immunol Allergy Clin North Am 43:273–287. https://doi.org/10.1016/j.iac.2023.01.007

Article  PubMed  Google Scholar 

Brown JC, Gerhardt TE, Kwon E (2023) Risk factors for coronary artery disease. StatPearls, Treasure Island

Google Scholar 

Okorare O, Evbayekha EO, Adabale OK, Daniel E, Ubokudum D, Olusiji SA, Antia AU (2023) Smoking cessation and benefits to cardiovascular health: a review of literature. Cureus 15:35966. https://doi.org/10.7759/cureus.35966

Article  Google Scholar 

Parmar MP, Kaur M, Bhavanam S, Mulaka GSR, Ishfaq L, Vempati R, C MF, Kandepi HV, Er R, Sahu S, Davalgi S (2023) A systematic review of the effects of smoking on the cardiovascular system and general health. Cureus 15:38073.https://doi.org/10.7759/cureus.38073

Pan B, Jin X, Jun L, Qiu S, Zheng Q, Pan M (2019) The relationship between smoking and stroke: a meta-analysis. Medicine 98:14872. https://doi.org/10.1097/MD.0000000000014872

Article  Google Scholar 

Markidan J, Cole JW, Cronin CA et al (2018) Smoking and risk of ischemic stroke in young men. Stroke 49:1276–1278. https://doi.org/10.1161/STROKEAHA.117.018859

Article  PubMed  PubMed Central  Google Scholar 

Hajdusianek W, Żórawik A, Waliszewska-Prosół M, Poręba R, Gać P (2021) Tobacco and nervous system development and function—new findings 2015–2020. Brain Sci 11:797. https://doi.org/10.3390/brainsci11060797

Article  CAS  PubMed  PubMed Central  Google Scholar 

Niu H, Qu Y, Li Z, Wang R, Li L, Li M, Lv X, Gao C, Song Y, Li B (2018) Smoking and risk for Alzheimer disease: a meta-analysis based on both case-control and cohort study. J Nerv Ment Dis 206:680–685. https://doi.org/10.1097/NMD.0000000000000859

Article  PubMed  Google Scholar 

Jasielski P, Piędel F, Rocka A, Petit V, Rejdak K (2020) Smoking as a risk factor of onset and relapse of multiple sclerosis — a review. Neurol Neurochir Pol 54:243–251. https://doi.org/10.5603/PJNNS.a2020.0032

Article  PubMed  Google Scholar 

CDCTobaccoFree (2023) Smoking and Cancer. https://www.cdc.gov/tobacco/campaign/tips/diseases/cancer.html. Accessed 25 Nov 2024

Hamadneh S, Hamadneh J (2021) Active and passive maternal smoking during pregnancy and birth outcomes: a study from a developing country. Ann Glob Health 87:122. https://doi.org/10.5334/aogh.3384

Article  PubMed  PubMed Central  Google Scholar 

Bergman M, Fountoukidis G, Smith D, Ahlgren J, Lambe M, Valachis A (2022) Effect of smoking on treatment efficacy and toxicity in patients with cancer: a systematic review and meta-analysis. Cancers 14:4117. https://doi.org/10.3390/cancers14174117

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zevin S, Benowitz NL (1999) Drug interactions with tobacco smoking: an update. Clin Pharmacokinet 36:425–438. https://doi.org/10.2165/00003088-199936060-00004

Article  CAS  PubMed  Google Scholar 

Manikandan P, Nagini S (2018) Cytochrome P450 structure, function and clinical significance: a review. Curr Drug Targets 19:38–54. https://doi.org/10.2174/1389450118666170125144557

Article  CAS  PubMed  Google Scholar 

Susa ST, Hussain A, Preuss CV (2023) Drug metabolism. StatPearls, Treasure Island

Google Scholar 

Gilani B, Cassagnol M (2023) Biochemistry, Cytochrome P450. StatPearls, Treasure Island

Google Scholar 

Guo J, Zhu X, Badawy S, Ihsan A, Liu Z, Xie C, Wang X (2021) Metabolism and mechanism of human cytochrome P450 enzyme 1A2. Curr Drug Metab 22:40–49. https://doi.org/10.2174/1389200221999210101233135

Article  CAS  PubMed  Google Scholar 

Faber MS, Jetter A, Fuhr U (2005) Assessment of CYP1A2 activity in clinical practice: why, how, and when? Basic Clin Pharmacol Toxicol 97:125–134. https://doi.org/10.1111/j.1742-7843.2005.pto_973160.x

Article  CAS  PubMed  Google Scholar 

Tantcheva-Poór I, Zaigler M, Rietbrock S, Fuhr U (1999) Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics 9:131–44. Erratum in: Pharmacogenetics 1999 9:781.

Hu DG, Mackenzie PI, Hulin JA, McKinnon RA, Meech R (2022) Regulation of human UDP-glycosyltransferase (UGT) genes by miRNAs. Drug Metab Rev 54:120–140. https://doi.org/10.1080/03602532.2022.2048846

Article  CAS  PubMed  Google Scholar 

Lozano R, Bona C (2023) Influence of cigarette smoking habit on clozapine-to-norclozapine ratio in male patients. J Res Pharm Pract 12:29–31. https://doi.org/10.4103/jrpp.jrpp_37_23

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kroon LA (2007) Drug interactions with smoking. Am J Health Syst Pharm 64:1917–1921. https://doi.org/10.2146/ajhp060414

Article  CAS  PubMed  Google Scholar 

Dobrinas M, Cornuz J, Oneda B, Kohler Serra M, Puhl M, Eap CB (2011) Impact of smoking, smoking cessation, and genetic polymorphisms on CYP1A2 activity and inducibility. Clin Pharmacol Ther 90:117–125. https://doi.org/10.1038/clpt.2011.70

Article  CAS  PubMed  Google Scholar 

Lucas C, Martin J (2013) Smoking and drug interactions. Aust Prescr 36:102–104. https://doi.org/10.18773/austprescr.2013.037

Scherf-Clavel M, Samanski L, Hommers LG, Deckert J, Menke A, Unterecker S (2019) Analysis of smoking behavior on the pharmacokinetics of antidepressants and antipsychotics: evidence for the role of alternative pathways apart from CYP1A2. Int Clin Psychopharmacol 34:93–100. https://doi.org/10.1097/YIC.0000000000000250

Article  PubMed  Google Scholar 

Dobrinas M, Cornuz J, Eap CB (2013) Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers. Pharmacogenet Genom 23:286–292. https://doi.org/10.1097/FPC.0b013e3283602e75

Article  CAS  Google Scholar 

Berm EJ, Ruijsbroek R, Loonen AJ, Goethals KR, Wilffert B, van Hasselt F (2015) Switching to e-cigarettes affects drug concentration. Ned Tijdschr Geneeskd 159:9090

Google Scholar 

Pan WC, Chen RM, Shen YC, Chen CC, Ueng YF (2009) Suppressive effect of tobacco smoke extracts on oral P-glycoprotein function and its impact in smoke-induced insult to oral epidermal cells. Toxicol Lett 185:116–123. https://doi.org/10.1016/j.toxlet.2008.12.007

Article  CAS  PubMed  Google Scholar 

Faber MS, Fuhr U (2004) Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther 76:178–184. https://doi.org/10.1016/j.clpt.2004.04.003

Article  CAS  PubMed  Google Scholar 

Juergens TM (2008) Adverse effects of ropinirole-treated restless leg syndrome (RLS) during smoking cessation. J Clin Sleep Med 4:371–372

Article  PubMed  PubMed Central  Google Scholar 

Bilal R, Ahmad NS, Zaffar S, Mazhar MU, Siddiqui WA, Tariq S (2022) Rasagiline pharmacokinetics in CYP1A2 variant healthy smokers & non-smokers in different doses. Pak J Med Sci 38:589–594. https://doi.org/10.12669/pjms.38.3.4940

Article  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:71. https://doi.org/10.1136/bmj.n71

Article  Google Scholar 

Jokinen M, Olkkola K, Ahonen J, Neuvonen P (2001) Effect of rifampin and tobacco smoking on the pharmacokinetics of ropivacaine. Clin Pharmacol Ther 70:344–350. https://doi.org/10.1016/S0009-9236(01)29243-1

Article  CAS  PubMed  Google Scholar 

Carrillo JA, Herráiz AG, Ramos SI, Gervasini G, Vizcaíno S, Benítez J (2003) Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine. J Clin Psychopharmacol 23:119–127. https://doi.org/10.1097/00004714-200304000-00003

Article  CAS